D. Narendar

Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation

B. Arun, D. Narendar, Kishan Veerabrahma · Artificial Cells Nanomedicine and Biotechnology · 2017 · 57 citations · Full text

Nanoparticles, Nanomedicine, Pharmaceutical Science +15

Development of olmesartan medoxomil optimized nanosuspension using the Box–Behnken design to improve oral bioavailability

K. Nagaraj, D. Narendar · Drug Development and Industrial Pharmacy · 2017 · 48 citations

Quality by design approach for development and optimization of Quetiapine Fumarate effervescent floating matrix tablets for improved oral bioavailability

D. Narendar, Nadarajan Arjun, Komuravelly Someshwar et al. · Journal of Pharmaceutical Investigation · 2016 · 33 citations

Pharmaceutical Science, Improved Oral Bioavailability, Medicine +5

Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats

G. Thirupathi, Ettireddy Swetha, D. Narendar · Drug Research · 2016 · 29 citations

Zotepine loaded lipid nanoparticles for oral delivery: development, characterization, and in vivo pharmacokinetic studies

B Nagaraj, Cernam Tirumalesh, Subramaniam Dinesh et al. · Future Journal of Pharmaceutical Sciences · 2020 · 28 citations · Full text

Nanoparticles, Oral Dosage Form, Pharmaceutical Science +17